Source: PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that it has entered into an exclusive agreement with Sandoz Inc., a Novartis company, pursuant to which Sandoz will distribute and commercialize Anacor's drug KERYDINTM (tavaborole) topical solution, 5% in the United States. PharmaDerm, the branded dermatology business of…...

Source: With a bid reaching nearly $55 billion and some goodies for the top execs, AbbVie ($ABBV) was finally able to get Ireland-based Shire ($SHPG) to surrender its independence, a portfolio of attention deficit hyperactivity disorder and rare disease drugs, and its low Irish tax base. Shire shareholders get £52.48…...

Source: Danish dermatology specialist LEO Pharma and Canada's KLOX Technologies, both privately-held companies, have entered into a worldwide license and joint venture agreement, excluding Canada, to further develop and commercialize KLOX's BioPhotonic technology platform in dermatology. The accord between the companies includes a "European Conformity" CE approved treatment for moderate…...

Source: FierceBiotech Innovative technology offers potential to transform eye care and further enhance Alcon's leadership in contact lenses and intraocular lenses Agreement is a first step for Novartis to evolve technology to manage human diseases and conditions Basel, Switzerland, July 15, 2014 - Novartis announced that its eye care division…...

Source: The pharmaceutical industry has shed thousands of sales representatives over the past decade, but drug makers continue to invest in hiring and training, albeit at rates that are only slightly higher than what was seen several years ago. The upshot is that the demise of these marketing stalwarts may have…...